Skip to main content
Journal of Ophthalmic Inflammation and Infection
Fig. 2 | Journal of Ophthalmic Inflammation and Infection

Fig. 2

From: Tuberculosis-related serpiginous choroiditis: aggressive therapy with dual concomitant combination of multiple anti-tubercular and multiple immunosuppressive agents is needed to halt the progression of the disease

Fig. 2

Patient 1 OS. Evolution of ICGA (intermediate angiographic phase). At presentation (A), widespread hypofluorescent, dark areas all over the fundus, indicating either chorioretinal atrophy or inflammatory choriocapillaris non perfusion; preservation of the central macula. Nine months after initiation of treatment (B), widespread areas over the whole fundus regain normal ICGA fluorescence indicating recovery of choriocapillaris perfusion; the remaining hypofluorescent areas correspond to chorioretinal atrophic areas. Three years after initiation of therapy (C), further slight recovery of choriocapillaris perfusion (normal ICGA fluorescence) and slight enlargement of the chorioretinal atrophic areas seen on B

Back to article page